Announcement

Collapse
No announcement yet.

Serological prevalence of avian H9N2 influenza virus in dogs by hemagglutination inhibition assay in Kerman, southeast of Iran

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Serological prevalence of avian H9N2 influenza virus in dogs by hemagglutination inhibition assay in Kerman, southeast of Iran


    Vet Res Forum. 2019 Summer;10(3):249-253. doi: 10.30466/vrf.2018.87879.2140. Epub 2019 Sep 15. Serological prevalence of avian H9N2 influenza virus in dogs by hemagglutination inhibition assay in Kerman, southeast of Iran.

    Saberi M1, Tavakkoli H1, Najmaddini A2, Rezaei M1.
    Author information

    1 Department of Clinical Sciences, Faculty of Veterinary Medicine, Shahid Bahonar University of Kerman, Kerman, Iran. 2 DVM Graduate,Faculty of Veterinary Medicine, Shahid Bahonar University of Kerman, Kerman, Iran.

    Abstract

    Influenza is a highly contagious zoonotic disease in the world. Avian H9N2 influenza virus is a significant pandemic pathogen widely distributed throughout the world. Pet ownership has been documented as a risk factor for infection transmission to human. Considering major public health concern, the prevalence of antibodies against avian H9N2 influenza virus was evaluated in 170 serum samples of dogs by hemagglutination inhibition assay. This study is the first survey to assess the epidemiology of avian H9N2 influenza virus infection in dogs in Kerman, southeast of Iran. Out of 170 samples, 65 (38.23%) were positive for H9N2. Antibodies were higher in farm dogs that were kept with other animals and also in dogs were fed a raw diet. These findings emphasize the importance of close attention to these populations for control and prevention programs. It is important to reduce infection burden, especially in regions with widespread distribution of H9N2.
    ? 2019 Urmia University. All rights reserved.


    KEYWORDS:

    Avian H9N2 influenza virus; Dog; Hemagglutination inhibition; Iran; Seroprevalence

    PMID: 31737235 PMCID: PMC6828164 DOI: 10.30466/vrf.2018.87879.2140


Working...
X